Genome wide SNP array identified multiple mechanisms of genetic changes in Waldenstrom macroglobulinemia

American Journal of Hematology

Volumn 88, Issue 11, 2013, Pages 948-954

  Poulain, Stéphanie ^a   Roumier, Christophe ^b,c   Galiègue Zouitina, Sylvie ^c   Daudignon, Agnès ^a   Herbaux, Charles ^b,c   Aiijou, Rachid ^a   Lainelle, Amélie ^a   Broucqsault, Natacha ^c   Bertrand, Elisabeth ^c   Manier, Salomon ^b,c   Renneville, Aline ^b   Soenen, Valérie ^b   Tricot, Sabine ^a   Roche Lestienne, Catherine ^b,c   Duthilleul, Patrick ^a   Preudhomme, Claude ^b,c   Quesnel, Bruno ^b,c   Morel, Pierre ^d   Leleu, Xavier ^b,c  

^a Service d'Hématologie Immunologie Cytogénétique   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c JEAN PIERRE AUBERT RESEARCH CENTER   (France)

^d Service d'Hematologie Clinique   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHROMOSOME 13; CHROMOSOME 4; CHROMOSOME DELETION; CHROMOSOME DELETION 6Q; CLINICAL ARTICLE; CONTROLLED STUDY; COPY NUMBER VARIATION; DNA METHYLATION; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; GENE MAPPING; GENE MUTATION; GENETIC ASSOCIATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; WALDENSTROEM MACROGLOBULINEMIA;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD79; CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; CHROMOSOME DUPLICATION; COHORT STUDIES; DNA COPY NUMBER VARIATIONS; DNA METHYLATION; FEMALE; FRANCE; GENE EXPRESSION REGULATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; MUTATION; TUMOR SUPPRESSOR PROTEINS; WALDENSTROM MACROGLOBULINEMIA;

EID: 84886233731     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23545     Document Type: Article

References (33)

1. Wang Y, Armstrong SA. Genome-wide SNP analysis in cancer: Leukemia shows the way. Cancer Cell 2007;11:308-309.
2. O'Keefe C, McDevitt MA, Maciejewski JP. Copy neutral loss of heterozygosity: A novel chromosomal lesion in myeloid malignancies. Blood 2010;115:2731-2739.
3. Nielaender I, Martin-Subero JI, Wagner F, et al. Partial uniparental disomy: A recurrent genetic mechanism alternative to chromosomal deletion in malignant lymphoma. Leukemia 2006;20:904-905.
4. O'Shea D, O'Riain C, Gupta M, et al. Regions of acquired uniparental disomy at diagnosis of follicular lymphoma are associated with both overall survival and risk of transformation. Blood 2009;113:2298-2301.
5. Vijay A, Gertz MA. Waldenstrom macroglobulinemia. Blood 2007;109:5096-5103.
6. Braggio E, Philipsborn C, Novak A, et al. Molecular pathogenesis of Waldenstrom's macroglobulinemia. Haematologica 2012;97:1281-1290.
7. Treon SP, Xu L, Yang G, et al. MYD88 L265P somatic mutation in Waldenstrom's macroglobulinemia. N Engl J Med 2012;367:826-833.
8. Schop RF, Van Wier SA, Xu R, et al. 6q deletion discriminates Waldenstrom macroglobulinemia from IgM monoclonal gammopathy of undetermined significance. Cancer Genet Cytogenet 2006;169:150-153.
9. Nguyen-Khac F, Lambert J, Chapiro E, et al. Chromosomal aberrations and their prognostic value in a series of 174 untreated patients with Waldenstrom's macroglobulinemia. Haematologica 2013;98:649-654.
10. Braggio E, Keats JJ, Leleu X, et al. Identification of copy number abnormalities and inactivating mutations in two negative regulators of nuclear factor-kappaB signaling pathways in Waldenstrom's macroglobulinemia. Cancer Res 2009;69:3579-3588.
11. Kyle RA, Benson JT, Larson DR, et al. Progression in smoldering Waldenstrom macroglobulinemia: Long-term results. Blood 2012;119:4462-4466.
12. Heinrichs S, Li C, Look AT. SNP array analysis in hematologic malignancies: Avoiding false discoveries. Blood 2010;115:4157-4161.
13. Yan Q, Huang Y, Watkins AJ, et al. BCR and TLR signaling pathways are recurrently targeted by genetic changes in splenic marginal zone lymphomas. Haematologica 2012;97:595-598.
14. Dunbar AJ, Gondek LP, O'Keefe CL, et al. 250K single nucleotide polymorphism array karyotyping identifies acquired uniparental disomy and homozygous mutations, including novel missense substitutions of c-Cbl, in myeloid malignancies. Cancer Res 2008;68:10349-10357.
15. Davis RE, Ngo VN, Lenz G, et al. Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma. Nature 2010;463:88-92.
16. Rahmatpanah FB, Carstens S, Hooshmand SI, et al. Large-scale analysis of DNA methylation in chronic lymphocytic leukemia. Epigenomics 2009;1:39-61.
17. Chng WJ, Schop RF, Price-Troska T, et al. Gene-expression profiling of Waldenstrom macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myeloma. Blood 2006;108:2755-2763.
18. Palamarchuk A, Efanov A, Nazaryan N, et al. 13q14 deletions in CLL involve cooperating tumor suppressors. Blood 2010;115:3916-3922.
19. Hammarsund M, Corcoran MM, Wilson W, et al. Characterization of a novel B-CLL candidate gene-DLEU7-located in the 13q14 tumor suppressor locus. FEBS Lett 2004;556:75-80.
20. Bea S, Salaverria I, Armengol L, et al. Uniparental disomies, homozygous deletions, amplifications, and target genes in mantle cell lymphoma revealed by integrative high-resolution whole-genome profiling. Blood 2009;113:3059-3069.
21. Pfeifer D, Pantic M, Skatulla I, et al. Genome-wide analysis of DNA copy number changes and LOH in CLL using high-density SNP arrays. Blood 2007;109:1202-1210.
22. Lopez-Corral L, Sarasquete ME, Bea S, et al. SNP-based mapping arrays reveal high genomic complexity in monoclonal gammopathies, from MGUS to myeloma status. Leukemia 2012;26:2521-2529.
23. Engel E. A fascination with chromosome rescue in uniparental disomy: Mendelian recessive outlaws and imprinting copyrights infringements. Eur J Hum Genet 2006;14:1158-1169.
24. Naylor TL, Tang H, Ratsch BA, et al. Protein kinase C inhibitor sotrastaurin selectively inhibits the growth of CD79 mutant diffuse large B-cell lymphomas. Cancer Res 2011;71:2643-2653.
25. Leleu X, Eeckhoute J, Jia X, et al. Targeting NF-kappaB in Waldenstrom macroglobulinemia. Blood 2008;111:5068-5077.
26. Ouillette P, Collins R, Shakhan S, et al. Acquired genomic copy number aberrations and survival in chronic lymphocytic leukemia. Blood 2011;118:3051-3061.
27. Ouillette P, Fossum S, Parkin B, et al. Aggressive chronic lymphocytic leukemia with elevated genomic complexity is associated with multiple gene defects in the response to DNA double-strand breaks. Clin Cancer Res 2010;16:835-847.
28. Honma K, Tsuzuki S, Nakagawa M, et al. TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas. Blood 2009;114:2467-2475.
29. Schmitz R, Hansmann ML, Bohle V, et al. TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma. J Exp Med 2009;206:981-989.
30. Terre C, Nguyen-Khac F, Barin C, et al. Trisomy 4, a new chromosomal abnormality in Waldenstrom's macroglobulinemia: A study of 39 cases. Leukemia 2006;20:1634-1636.
31. Rinaldi A, Mian M, Chigrinova E, et al. Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome. Blood 2011;117:1595-1604.
32. Braggio E, Dogan A, Keats JJ, et al. Genomic analysis of marginal zone and lymphoplasmacytic lymphomas identified common and disease-specific abnormalities. Mod Pathol 2012;25:651-660.
33. Schop RF, Jalal SM, Van Wier SA, et al. Deletions of 17p13.1 and 13q14 are uncommon in Waldenstrom macroglobulinemia clonal cells and mostly seen at the time of disease progression. Cancer Genet Cytogenet 2002;132:55-60.